Head-to-head · WeighScore
9amHealth vs Roen Rx
The verdict
9amHealth takes it — 71.3/100 to 55.4/100.
9amHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. 9amHealth (join9am.com) is a cardiometabolic telehealth platform offering whole-body care including weight management with FDA-approved branded GLP-1 medications such as Wegovy, Zepbound, and Saxenda, plus FDA-approved generics.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | 9amHealth | Roen Rx |
|---|---|---|
| WeighScore | 71.3/100 | 55.4/100 |
| Grade | C | C |
| Scorecard rank | #105 | #481 |
| Semaglutide | $149/mo (plus a separate fee, brand-name) | $151/mo (3-month plan, plus a separate fee, compounded) |
| Tirzepatide | Not disclosed | $216/mo (plus a separate fee, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #105 · C
Strengths
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
- $149/month membership or free when covered by insurance
- Membership includes specialists, labs, devices, and medications
- Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
- Helps navigate insurance approvals; employer and state-plan partnerships
Where it loses points
- Medication coverage and GLP-1 access depend on insurance and BMI criteria
- State availability not enumerated on the public site
- Branded GLP-1s can be costly without insurance coverage
- Pricing for medications not transparently listed
Graded #481 · C
FDAWarning letter issued to Roen Health, Inc. dba RoenRx in June 2026. See the FDA warning-letter database.
Strengths
- Insurance coordination for brand-name GLP-1s — as low as $25/mo
- Both compounded and brand-name options
- LegitScript approved with Compounded USA badge
- Compounded semaglutide from $151/mo quarterly
- Also offers primary care, mental health, and other specialties
Where it loses points
- State availability not publicly disclosed
- Insurance coordination may not work for all plans
- Broader platform (ED, hair loss, skincare, birth control)
- Requires a separate membership (first month $39); GLP-1 medications are NOT included in the membership fee - medication is billed on top
- FDA issued Roen Health, Inc. dba RoenRx a warning letter in June 2026; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.